About Genomics
Genomics is a company based in Oxford (United Kingdom) founded in 2014 by Gil McVean and Peter Donnelly. It operates as a AI-as-a-Service, Professional Services, and HealthTech. Genomics has raised $115.54 million across 10 funding rounds from investors including Vertex Pharmaceuticals, HHS and University of Oxford. Genomics offers products and services including Health Insights, Drug Discovery Platform, and Precision Health Tools.
- Headquarter Oxford, United Kingdom
- Founders Gil McVean, Peter Donnelly
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genomics Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$115.54 M (USD)
in 10 rounds
-
Latest Funding Round
$44.51 M (USD), Series C
Jan 08, 2024
-
Investors
Vertex Pharmaceuticals
& 13 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genomics
Genomics offers a comprehensive portfolio of products and services, including Health Insights, Drug Discovery Platform, and Precision Health Tools. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Personalized health insights are provided through genomic analysis.
Drug discovery is accelerated using population-scale genetic data.
Precision health delivery is enabled through genetic stratification.
Funding Insights of Genomics
Genomics has successfully raised a total of $115.54M across 10 strategic funding rounds. The most recent funding activity was a Series C round of $44.51 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series C — $44.5M
-
First Round
First Round
(15 Apr 2014)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series C - Genomics | Valuation | F-Prime Capital | |
| Dec, 2018 | Amount | Series B - Genomics | Valuation | Foresite Capital | |
| Aug, 2018 | Amount | Series B - Genomics | Valuation | Vertex Pharmaceuticals |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genomics
Genomics has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Vertex Pharmaceuticals, HHS and University of Oxford. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location | |
|
Corporate-backed venture capital fund
|
Founded Year | Domain | Location | |
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genomics Comparisons
Competitors of Genomics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Genomics
When was Genomics founded?
Genomics was founded in 2014.
Where is Genomics located?
Genomics is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Who is the current CEO of Genomics?
Peter Donnelly is the current CEO of Genomics. They have also founded this company.
Is Genomics a funded company?
Genomics is a funded company, having raised a total of $115.54M across 10 funding rounds to date. The company's 1st funding round was a Series B of $32.32M, raised on Apr 15, 2014.
What does Genomics do?
Genomics is engaged in harnessing genetic data to improve population health and accelerate drug discovery. Solutions are provided for healthcare providers, employers, life sciences, and partners through predictive genomics and personalized health insights. The company operates in the biotechnology sector, focusing on disease risk prediction and precision health delivery. Collaborations are maintained with global pharmaceutical companies and research institutions to develop innovative treatments and screening methods.
What products or services does Genomics offer?
Genomics offers Health Insights, Drug Discovery Platform, and Precision Health Tools.
Who are Genomics's investors?
Genomics has 14 investors. Key investors include Vertex Pharmaceuticals, HHS, University of Oxford, IP Group, and Invesco Mutual Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.